nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—SLCO1A2—Glyburide—gestational diabetes	0.435	0.513	CbGbCtD
Naloxone—ALB—Glyburide—gestational diabetes	0.225	0.265	CbGbCtD
Naloxone—ABCB1—Glyburide—gestational diabetes	0.118	0.139	CbGbCtD
Naloxone—CYP3A4—Glyburide—gestational diabetes	0.0704	0.0831	CbGbCtD
Naloxone—TLR4—adipose tissue—gestational diabetes	0.00769	0.159	CbGeAlD
Naloxone—CREB1—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.00751	0.072	CbGpPWpGaD
Naloxone—CREB1—islet of Langerhans—gestational diabetes	0.00531	0.11	CbGeAlD
Naloxone—CREB1—embryo—gestational diabetes	0.00513	0.106	CbGeAlD
Naloxone—CREB1—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.00371	0.0356	CbGpPWpGaD
Naloxone—CREB1—uterus—gestational diabetes	0.00346	0.0716	CbGeAlD
Naloxone—CREB1—adipose tissue—gestational diabetes	0.00338	0.0701	CbGeAlD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.00329	0.0315	CbGpPWpGaD
Naloxone—CREB1—vagina—gestational diabetes	0.00281	0.0583	CbGeAlD
Naloxone—CREB1—FSH signaling pathway—CYP19A1—gestational diabetes	0.0028	0.0268	CbGpPWpGaD
Naloxone—CREB1—head—gestational diabetes	0.0026	0.0538	CbGeAlD
Naloxone—CREB1—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.00259	0.0248	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—LEPR—gestational diabetes	0.00246	0.0236	CbGpPWpGaD
Naloxone—CREB1—Nongenotropic Androgen signaling—AR—gestational diabetes	0.00244	0.0234	CbGpPWpGaD
Naloxone—CREB1—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.00231	0.0221	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—RETN—gestational diabetes	0.00229	0.0219	CbGpPWpGaD
Naloxone—CREB1—Circadian Clock—NAMPT—gestational diabetes	0.00218	0.0209	CbGpPWpGaD
Naloxone—OPRD1—head—gestational diabetes	0.00205	0.0425	CbGeAlD
Naloxone—CREB1—SREBP signalling—RBP4—gestational diabetes	0.00203	0.0194	CbGpPWpGaD
Naloxone—ESR1—embryo—gestational diabetes	0.00202	0.0418	CbGeAlD
Naloxone—OPRK1—head—gestational diabetes	0.00197	0.0408	CbGeAlD
Naloxone—CREB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00187	0.018	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—LEP—gestational diabetes	0.00172	0.0165	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—LEPR—gestational diabetes	0.00161	0.0155	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00142	0.0136	CbGpPWpGaD
Naloxone—OPRM1—head—gestational diabetes	0.0014	0.029	CbGeAlD
Naloxone—ESR1—uterus—gestational diabetes	0.00136	0.0282	CbGeAlD
Naloxone—ESR1—Nuclear Receptors—AR—gestational diabetes	0.00136	0.013	CbGpPWpGaD
Naloxone—ESR1—adipose tissue—gestational diabetes	0.00133	0.0276	CbGeAlD
Naloxone—ESR1—FOXA1 transcription factor network—AR—gestational diabetes	0.00121	0.0116	CbGpPWpGaD
Naloxone—SLCO1A2—head—gestational diabetes	0.00121	0.025	CbGeAlD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.00113	0.0108	CbGpPWpGaD
Naloxone—ESR1—vagina—gestational diabetes	0.00111	0.0229	CbGeAlD
Naloxone—CREB1—Adipogenesis—NAMPT—gestational diabetes	0.0011	0.0105	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—GLS2—gestational diabetes	0.00109	0.0104	CbGpPWpGaD
Naloxone—ESR1—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00107	0.0103	CbGpPWpGaD
Naloxone—CREB1—Transcription factor regulation in adipogenesis—TNF—gestational diabetes	0.00107	0.0102	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—MBL2—gestational diabetes	0.00105	0.0101	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—AR—gestational diabetes	0.00105	0.0101	CbGpPWpGaD
Naloxone—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.00102	0.00982	CbGpPWpGaD
Naloxone—ESR1—head—gestational diabetes	0.00102	0.0212	CbGeAlD
Naloxone—CREB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000958	0.00918	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000941	0.00902	CbGpPWpGaD
Naloxone—CREB1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.000939	0.009	CbGpPWpGaD
Naloxone—CYP2C8—vagina—gestational diabetes	0.000912	0.0189	CbGeAlD
Naloxone—CREB1—Adipogenesis—ADIPOQ—gestational diabetes	0.000896	0.0086	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000896	0.00859	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000884	0.00848	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—LEP—gestational diabetes	0.000865	0.00829	CbGpPWpGaD
Naloxone—CREB1—Phospholipase C-mediated cascade—FGF2—gestational diabetes	0.00083	0.00796	CbGpPWpGaD
Naloxone—ABCB1—islet of Langerhans—gestational diabetes	0.000825	0.0171	CbGeAlD
Naloxone—OPRK1—Mecp2 and Associated Rett Syndrome—FGF2—gestational diabetes	0.00082	0.00787	CbGpPWpGaD
Naloxone—ABCB1—embryo—gestational diabetes	0.000798	0.0165	CbGeAlD
Naloxone—TLR4—Spinal Cord Injury—TNF—gestational diabetes	0.000797	0.00765	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000778	0.00746	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—NAMPT—gestational diabetes	0.000773	0.00741	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.00074	0.0071	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000727	0.00697	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000722	0.00692	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000706	0.00677	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000699	0.00671	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000687	0.00659	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000682	0.00654	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000669	0.00642	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000649	0.00622	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000633	0.00607	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000633	0.00607	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000619	0.00593	CbGpPWpGaD
Naloxone—TLR4—Immune System—MBL2—gestational diabetes	0.000613	0.00588	CbGpPWpGaD
Naloxone—CREB1—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.000589	0.00564	CbGpPWpGaD
Naloxone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000588	0.00564	CbGpPWpGaD
Naloxone—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00058	0.00556	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000577	0.00553	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000569	0.00546	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—LEP—gestational diabetes	0.000566	0.00543	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—LEP—gestational diabetes	0.000557	0.00534	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000542	0.0052	CbGpPWpGaD
Naloxone—ABCB1—uterus—gestational diabetes	0.000538	0.0111	CbGeAlD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000535	0.00513	CbGpPWpGaD
Naloxone—CREB1—PI-3K cascade—FGF2—gestational diabetes	0.00053	0.00508	CbGpPWpGaD
Naloxone—ABCB1—adipose tissue—gestational diabetes	0.000526	0.0109	CbGeAlD
Naloxone—CREB1—PI3K/AKT activation—FGF2—gestational diabetes	0.000518	0.00496	CbGpPWpGaD
Naloxone—CREB1—GAB1 signalosome—FGF2—gestational diabetes	0.000514	0.00492	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000506	0.00485	CbGpPWpGaD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.000502	0.00481	CbGpPWpGaD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000476	0.00457	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000471	0.00452	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000462	0.00443	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000458	0.0044	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.00045	0.00431	CbGpPWpGaD
Naloxone—ABCB1—vagina—gestational diabetes	0.000437	0.00906	CbGeAlD
Naloxone—OPRK1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000413	0.00396	CbGpPWpGaD
Naloxone—ABCB1—head—gestational diabetes	0.000404	0.00837	CbGeAlD
Naloxone—CREB1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000396	0.0038	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—LEP—gestational diabetes	0.000393	0.00377	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.00039	0.00374	CbGpPWpGaD
Naloxone—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00039	0.00374	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000387	0.00371	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000379	0.00364	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—GCK—gestational diabetes	0.000374	0.00359	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—FGF2—gestational diabetes	0.000373	0.00358	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000373	0.00357	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—FGF2—gestational diabetes	0.000368	0.00353	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—MBL2—gestational diabetes	0.000368	0.00353	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—FGF2—gestational diabetes	0.000356	0.00342	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—FGF2—gestational diabetes	0.000355	0.0034	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—FGF2—gestational diabetes	0.000353	0.00338	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—FGF2—gestational diabetes	0.000351	0.00337	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000349	0.00335	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000346	0.00332	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000332	0.00318	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00033	0.00317	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—FGF2—gestational diabetes	0.00033	0.00317	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00033	0.00317	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—FGF2—gestational diabetes	0.000327	0.00314	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000325	0.00311	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—FGF2—gestational diabetes	0.000323	0.0031	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000315	0.00302	CbGpPWpGaD
Naloxone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000311	0.00299	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000311	0.00298	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ADIPOQ—gestational diabetes	0.000308	0.00295	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—FGF2—gestational diabetes	0.000306	0.00293	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000293	0.00281	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000266	0.00255	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—TNF—gestational diabetes	0.000258	0.00247	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000257	0.00247	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000256	0.00245	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GGCT—gestational diabetes	0.000253	0.00243	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000253	0.00243	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00025	0.00239	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000247	0.00237	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—FGF2—gestational diabetes	0.000244	0.00234	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000242	0.00233	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000242	0.00232	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000233	0.00224	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGF2—gestational diabetes	0.000225	0.00216	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000223	0.00213	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GLS2—gestational diabetes	0.000221	0.00212	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000215	0.00207	CbGpPWpGaD
Naloxone—TLR4—Immune System—FGF2—gestational diabetes	0.000214	0.00205	CbGpPWpGaD
Naloxone—CREB1—Immune System—MBL2—gestational diabetes	0.000214	0.00205	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000212	0.00203	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000204	0.00195	CbGpPWpGaD
Naloxone—CREB1—Disease—RBP4—gestational diabetes	0.000199	0.00191	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000198	0.0019	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000197	0.00189	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000197	0.00189	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—LEP—gestational diabetes	0.000191	0.00184	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000189	0.00182	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—AR—gestational diabetes	0.000185	0.00178	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—LEPR—gestational diabetes	0.000181	0.00174	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—LEPR—gestational diabetes	0.000181	0.00173	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000179	0.00172	CbGpPWpGaD
Naloxone—CREB1—Disease—NAMPT—gestational diabetes	0.000179	0.00171	CbGpPWpGaD
Naloxone—CREB1—Disease—GCK—gestational diabetes	0.000178	0.0017	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TNF—gestational diabetes	0.000175	0.00168	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—LEPR—gestational diabetes	0.000158	0.00152	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—FGF2—gestational diabetes	0.000145	0.00139	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MTNR1B—gestational diabetes	0.000143	0.00137	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MTNR1B—gestational diabetes	0.000143	0.00137	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RBP4—gestational diabetes	0.00014	0.00134	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	0.000139	0.00133	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RBP4—gestational diabetes	0.000139	0.00133	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000136	0.0013	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000134	0.00128	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—LEPR—gestational diabetes	0.000134	0.00128	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000133	0.00127	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF2—gestational diabetes	0.000128	0.00123	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000126	0.0012	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000125	0.0012	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GGCT—gestational diabetes	0.000124	0.00119	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000124	0.00119	CbGpPWpGaD
Naloxone—ALB—Metabolism—GGCT—gestational diabetes	0.000124	0.00119	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF2—gestational diabetes	0.000123	0.00118	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RBP4—gestational diabetes	0.000122	0.00117	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NAMPT—gestational diabetes	0.000121	0.00116	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GCK—gestational diabetes	0.00012	0.00116	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—LEPR—gestational diabetes	0.000119	0.00114	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00011	0.00106	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GLS2—gestational diabetes	0.000109	0.00104	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGCT—gestational diabetes	0.000108	0.00104	CbGpPWpGaD
Naloxone—ALB—Metabolism—GLS2—gestational diabetes	0.000108	0.00104	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000108	0.00103	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MTNR1B—gestational diabetes	0.000106	0.00101	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RBP4—gestational diabetes	0.000103	0.000989	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.72e-05	0.000932	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.66e-05	0.000927	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GLS2—gestational diabetes	9.47e-05	0.000908	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MTNR1B—gestational diabetes	9.38e-05	0.0009	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RBP4—gestational diabetes	9.14e-05	0.000877	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AR—gestational diabetes	8.92e-05	0.000855	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—gestational diabetes	8.85e-05	0.000849	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP19A1—gestational diabetes	8.81e-05	0.000845	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF2—gestational diabetes	7.48e-05	0.000717	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF2—gestational diabetes	6.9e-05	0.000662	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGCT—gestational diabetes	6.68e-05	0.00064	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.56e-05	0.000629	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—LEP—gestational diabetes	6.36e-05	0.00061	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—LEP—gestational diabetes	6.34e-05	0.000608	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NAMPT—gestational diabetes	5.96e-05	0.000571	CbGpPWpGaD
Naloxone—ALB—Metabolism—NAMPT—gestational diabetes	5.92e-05	0.000568	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GCK—gestational diabetes	5.92e-05	0.000568	CbGpPWpGaD
Naloxone—ALB—Metabolism—GCK—gestational diabetes	5.89e-05	0.000564	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GLS2—gestational diabetes	5.84e-05	0.00056	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—LEP—gestational diabetes	5.56e-05	0.000533	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NAMPT—gestational diabetes	5.19e-05	0.000498	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GCK—gestational diabetes	5.16e-05	0.000494	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF2—gestational diabetes	4.83e-05	0.000464	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF2—gestational diabetes	4.82e-05	0.000462	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—LEP—gestational diabetes	4.7e-05	0.000451	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP19A1—gestational diabetes	4.33e-05	0.000415	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP19A1—gestational diabetes	4.3e-05	0.000413	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF2—gestational diabetes	4.23e-05	0.000405	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—LEP—gestational diabetes	4.17e-05	0.0004	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP19A1—gestational diabetes	3.77e-05	0.000362	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF2—gestational diabetes	3.57e-05	0.000342	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NAMPT—gestational diabetes	3.2e-05	0.000307	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GCK—gestational diabetes	3.18e-05	0.000305	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF2—gestational diabetes	3.17e-05	0.000304	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP19A1—gestational diabetes	2.32e-05	0.000223	CbGpPWpGaD
